Table 1 Demographics (n = 1545). Data are presented as n or mean ± standard deviation. *p-value < 0.05 was considered statistically significant after test. ORIF open reduction and internal fixation, PRASG pre-aged society group, POASG post-aged society group, HTN hypertension, DM diabetes mellitus, CRF chronic renal failure, CAD coronary artery disease, CVA cerebrovascular accident, GI gastrointestinal, UGI upper gastrointestinal.
Variables | Period 1 (2010–2017) PRASG | Period 2 (2018–2022) POASG | Total | p-value | ||
|---|---|---|---|---|---|---|
N | 663 | 882 | 1545 | |||
Age | 78.82 ± 9.12 | 78.85 ± 9.27 | 78.84 ± 9.20 | 0.956 | ||
Gender | - | - | - | 0.962 | ||
Male | 230 (34.7%) | 307 (34.8%) | 537 (34.8%) | |||
Female | 433 (65.3%) | 575 (65.2%) | 1008 (65.2%) | |||
BMI | 23.87 ± 5.05 | 23.40 ± 4.85 | 23.60 ± 4.94 | 0.067 | ||
Surgical methods | - | - | - | < 0.001* | ||
ORIF with CHS | 142 (21.4%) | 27 (3.1%) | 169 (10.9%) | |||
ORIF with Nail | 290 (43.7%) | 539 (61.1%) | 829 (53.7%) | |||
Hemiarthroplasty | 231 (34.8%) | 316 (35.8%) | 547 (35.4%) | |||
Waiting period to Surgery | - | - | - | 0.360 | ||
≤ 48 h | 535 (80.7%) | 695 (78.8%) | 1230 (79.6%) | |||
> 48 h | 128 (19.3%) | 187 (21.2%) | 315 (20.4%) | |||
ASA | - | - | - | 0.107 | ||
I-II | 405 (61.1%) | 574 (65.1%) | 979 (63.4%) | |||
III-IV | 258 (38.9%) | 308 (34.9%) | 566 (36.6%) | |||
Spinal anesthesia (%) | 220 (33.2%) | 301 (34.1%) | 521 (33.7%) | 0.698 | ||
Comorbidity | ||||||
Dementia (%) | 88 (13.3%) | 136 (15.4%) | 224 (14.5%) | 0.236 | ||
HTN (%) | 446 (67.3%) | 619 (70.2%) | 1065 (68.9%) | 0.221 | ||
DM (%) | 270 (40.7%) | 342 (38.8%) | 612 (39.6%) | 0.438 | ||
Dyslipidemia (%) | 248 (37.4%) | 361 (40.9%) | 609 (39.4%) | 0.161 | ||
Hepatic disease (%) | 78 (11.8%) | 102 (11.6%) | 180 (11.7%) | 0.903 | ||
CRF (%) | 133 (20.1%) | 201 (22.8%) | 334 (21.6%) | 0.197 | ||
CAD (%) | 138 (20.8%) | 200 (22.7%) | 338 (21.9%) | 0.381 | ||
CVA (%) | 149 (22.5%) | 234 (26.5%) | 383 (24.8%) | 0.068 | ||
GI disease (%) | 251 (37.9%) | 334 (37.9%) | 585 (37.9%) | 0.997 | ||
Chronic lung disease (%) | 155 (23.4%) | 237 (26.9%) | 392 (25.4%) | 0.118 | ||
In hospital complication | ||||||
Aspiration pneumonia (%) | 13 (2.0%) | 17 (1.9%) | 30 (1.9%) | 0.963 | ||
Urinary tract infection (%) | 71 (10.7%) | 104 (11.8%) | 175 (11.3%) | 0.506 | ||
UGI bleeding (%) | 21 (3.2%) | 41 (4.6%) | 62 (4.0%) | 0.142 | ||
Death within postoperative 1 year (%) | 43 (6.5%) | 49 (5.6%) | 92 (6.0%) | 0.444 | ||
